The company’s board of directors approved a new $75M stock repurchase program. The 2025 repurchase program is in addition to the stock repurchase program approved by the board on August 2, 2016 providing for the repurchase of up to $50M of the company’s common stock.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMCL:
- Omnicell narrows FY25 EPS view to $1.30-$1.65 from $1.00-$1.65
- Omnicell raises Q2 EPS view to 24c-34c from 19c-32c, consensus 25c
- Omnicell announces new products for perioperative and clinic settings
- Omnicell opens new Innovation Lab in Austin, Texas
- Omnicell upgraded to Overweight from Equal Weight at Wells Fargo